vimarsana.com

Page 119 - வர்த்தகம் தொடர்புடையது அம்சங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Daily Podcast – May 10, 2021

Daily Podcast – May 10, 2021 Search Polity Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range. To search for a term containing the & symbol, click Advanced Search and use the search headings and/or in first paragraph options. With. Clear Search Sponsored by Sponsored by Daily Podcast – May 10, 2021 To play this media please enable JavaScript, and consider upgrading to a web browser that supports HTML5 media 10th May 2021 Nadine Ramdass. Making headlines: Ramaphosa says vaccine should be made available to all, not just to the highest bidders, Nersa urges stakeholders to join it in opposing Eskom’s latest court challenge and, Eastern Cape premier to take action against Magashule over stolen money claims

Procedures and strategies for anti-counterfeiting: Turkey

Legal framework Turkey is a party to a number of international conventions, including the Paris Convention, the Agreement on Trade-Related Aspects of Intellectual Property Rights and the Berne Convention. Turkey also has specific national legislation, including: the Industrial Property Code 6769; the Law on Turkish Intellectual and Artistic Works (5846) (known as the Copyright Act); the Code of Commerce; the Anti-smuggling Law; and Law 5651 on Regulating Broadcasting in the Internet and Fighting Against Crimes Committed through Internet Broadcasting (known as the Internet Law). Border measures According to Turkish legislation, it is possible to register IP rights (ie, trademarks, industrial designs, patents, utility models, copyrights, geographical indications, integrated circuit topographies and plant breeders’ rights) before Customs, as the crucial first step in the fight against counterfeiting.

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues Jacquelyn LeBel © supplied by Biolyse Pharma Biolyse Pharma in St. Catharines, Ont., is hoping to obtain a compulsory licence. A Canadian company hoping to contribute to the world’s vaccination efforts says it has reached a deal to provide 15 million doses of the single-dose Johnson & Johnson/Janssen COVID-19 vaccine to Bolivia, but it cannot move ahead until it is allowed to actually produce it. Biolyse Pharma, an Ontario-based manufacturer, says it already has the capacity to produce up to 20 million doses annually of an already-approved viral-vector COVID-19 vaccine, like the AstraZeneca or Johnson & Johnson vaccines, with the potential to produce 50 million doses.

India s focus must be how to come out of current COVID crisis, says Canadian Envoy

High Commissioner of Canada to India, Nadir Patel (ANI) India s focus must be how to come out of current COVID crisis, says Canadian Envoy ANI | Updated: May 11, 2021 20:23 IST New Delhi [India], May 11 (ANI): High Commissioner of Canada to India, Nadir Patel on Tuesday said that the focus should not be on the rise in coronavirus cases in India due to the B1617 virus variant rather on how to assist to address this situation so that the crisis is mitigated. It would be easy to see how significant rise in this particular variant in terms of cases. We are moving forward to address this and getting on other side of this, said Patel on Indian variant of coronavirus B.1.617 variant, which WHO has classified as a variant of concern.

The Global Clamour for Ending Vaccine Inequalities Must Go Beyond Just the IP Issue

The Global Clamour for Ending Vaccine Inequalities Must Go Beyond Just the IP Issue The COVID-19 crisis has made it increasingly clear that the corporate-led world neither values human life nor the challenges that we face. A citizen receives a dose of the AstraZeneca COVID-19 vaccine near Rio de Janeiro, Brazil, April 21, 2021. Photo: REUTERS/Ricardo Moraes/File Photo World11/May/2021 Bowing to pressure from fellow Democrats and amidst rising global clamour for sharing resources, technology and perhaps most importantly, the much-needed technical know-how with the developing world to deal with the COVID-19 pandemic, the US President Joe Biden finally agreed to support patent waiver for vaccines at the World Trade Organisation (WTO).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.